The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditya Birla Sun Life Mutual Fund
NATHBIOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aditya Birla Sun Life Mutual Fund (a non-promoter institutional investor) has reduced its holding in Nath Bio-Genes (India) Ltd by selling 3,95,408 shares (2.0806% of paid-up capital) in the open market on May 13, 2025. The fund's aggregate holding has come down from 5.2828% (10,03,946 shares) to 3.2022% (6,08,538 shares), a drop of roughly 39% of its earlier stake. The disclosure is filed under SEBI's Takeover Regulations and the shares were sold purely in the open market with no encumbrance involved. The company's total share capital remains unchanged at Rs. 19,00,40,000 (1,90,04,000 shares of Rs. 10 each).
A meaningful cut in institutional/mutual fund holding is generally viewed as a negative sentiment signal, since a well-known fund exiting a sizeable chunk of its position often weighs on short-term price action and may raise questions about the stock's near-term outlook among retail investors.